KAISER PERMANENTE TERBINAFINE HYDROCHLORIDE (TERBINAFINE HYDROCHLORIDE) CREAM [KAISER FOUNDATION HOSPITALS]

  • Home
  • KAISER PERMANENTE TERBINAFINE HYDROCHLORIDE (TERBINAFINE HYDROCHLORIDE) CREAM [KAISER FOUNDATION HOSPITALS]

KAISER PERMANENTE TERBINAFINE HYDROCHLORIDE (TERBINAFINE HYDROCHLORIDE) CREAM [KAISER FOUNDATION HOSPITALS]
PDF | XML
NDC 0179-8715-30
Set ID 2a342421-fc4b-4c21-a394-5ddb9d4a96d5
Category HUMAN OTC DRUG LABEL
Packager Kaiser Foundation Hospitals
Generic Name
Product Class Allylamine Antifungal
Product Number
Application Number ANDA077511
View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Terbinafine hydrochloride 1%

  • Purpose

    Antifungal

  • Uses

    • cures most athlete's foot (tinea pedis)
    • cures most jock itch (tinea cruris) and ringworm (tinea corporis)
    • relieves itching, burning, cracking and scaling which accompany these conditions
  • Warnings

    For external use only

    Do not use

    • on nails or scalp
    • in or near the mouth or the eyes
    • for vaginal yeast infections

    When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.

    Stop use and ask a doctor if

    • too much irritation occurs or gets worse.

    Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.

  • Directions

    • adults and children 12 years and older
      • use the tip of the cap to break the seal and open the tube
      • wash the affected skin with soap and water and dry completely before applying
      • for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
        • between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor.
        • on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor.
      • for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor.
      • wash hands after each use
    • children under 12 years: ask a doctor
    		1 week between the toes
    Image
    2 weeks on the bottom
    or sides of the foot
    Image
  • Other information

    • do not use if seal on tube is broken or is not visible
    • store at controlled room temperature 20°-25°C (68°-77°F)
    • see carton or tube crimp for lot number and expiration date
  • Inactive ingredients

    benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

  • Questions?

    Call 1-866-923-4914

  • SPL UNCLASSIFIED SECTION

    Manufactured by
    Taro Pharmaceuticals Inc.
    Brampton, Ontario, Canada L6T 1C1
    Distributed by
    Kaiser Foundation Hospitals
    Livermore, CA 94551-9756

  • PRINCIPAL DISPLAY PANEL - 30 g Tube Carton

    KAISER PERMANENTE ®

    Terbinafine Hydrochloride Cream 1%
    ANTIFUNGAL CREAM
    CURES MOST ATHLETE'S FOOT

    Compare to the active ingredient in Lamisil AT ®*

    NET WT 1 OZ (30 g)

    Principal Display Panel - 30 g Tube Carton
  • INGREDIENTS AND APPEARANCE
    KAISER PERMANENTE  TERBINAFINE HYDROCHLORIDE
    terbinafine hydrochloride cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0179-8715
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE1 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    CETYL PALMITATE (UNII: 5ZA2S6B08X)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0179-8715-301 in 1 CARTON07/02/200706/30/2020
    130 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07751107/02/200706/30/2020
    Labeler - Kaiser Foundation Hospitals (053052619)
    Registrant - Taro Pharmaceuticals U.S.A., Inc. (145186370)
    Establishment
    NameAddressID/FEIBusiness Operations
    Taro Pharmaceuticals Inc.206263295manufacture(0179-8715)
View All Sections

Related Drugs

Search DailyMed Drugs